Repligen Rises as Investors Weigh M&A Progress and Fresh Bullish Signals
Why now
Thesis: Life-sciences supplier gains on M&A optimism
Catalyst to watch: Deal announcements and earnings
Main risk: M&A stalls, sentiment reverses
Why it matters
M&A progress and bullish signals lift a life-sciences supplier, hinting at bioprocessing demand recovery.
Sources
- googlenews · news.google.com · 2026-09-28 17:36 UTC